Efficacy and Safety of NVX-CoV2705

Clinical trial NCT07086222 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07086222
Sponsor: Novavax
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Sars-CoV-2 Infection

Start date: 2025-11-20
Primary completion: 2026-11-18
Enrollment: 6500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.